HDAC8-IN-22d
CAS No. 1417997-93-3
HDAC8-IN-22d ( HDAC8-IN-1; MDK-7933; MDK 7933; MDK7933 )
Catalog No. M11745 CAS No. 1417997-93-3
HDAC8-IN-22d is a potent, selective HDAC8 inhibitor with IC50 of 27.2 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 59 | In Stock |
|
5MG | 91 | In Stock |
|
10MG | 139 | In Stock |
|
25MG | 278 | In Stock |
|
50MG | 431 | In Stock |
|
100MG | 550 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHDAC8-IN-22d
-
NoteResearch use only, not for human use.
-
Brief DescriptionHDAC8-IN-22d is a potent, selective HDAC8 inhibitor with IC50 of 27.2 nM.
-
DescriptionHDAC8-IN-22d is a potent, selective HDAC8 inhibitor with IC50 of 27.2 nM, exhibits no activity against other HDACs and limited activity against HDAC1 and 3; shows antiproliferative effects toward several human lung cancer cell lines (A549, H1299, and CL1-5); exhibits cytotoxicity against human lung CL1-5 cells (IC50=7.0 uM) similar to that of SAHA yet without significant cytotoxicity for normal IMR-90 cells.
-
SynonymsHDAC8-IN-1; MDK-7933; MDK 7933; MDK7933
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC8
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1417997-93-3
-
Formula Weight345.40
-
Molecular FormulaC22H19NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 130 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESONC(/C=C/C1=CC=C(C=C1C2=CC=C(C=C2)C3=CC=CC=C3)OC)=O
-
Chemical Name(2E)-N-Hydroxy-3-(5-methoxy[1,1':4',1''-terphenyl]-2-yl)-2-propenamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang WJ, et al. ChemMedChem. 2012 Oct;7(10):1815-24.
molnova catalog
related products
-
AES-350
AES-350 is a potent and orally active HDAC6 inhibitor(IC50 and a Ki of 0.0244 μM and 0.035 μM, respectively).
-
NSC 3852
NSC 3852 is a potent inhibitor of histone deacetylase.
-
Belinostat
Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.